- Report
- February 2026
- 375 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 383 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 279 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 272 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 131 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 456 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 368 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 276 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 258 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- November 2025
- 150 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- May 2025
- 236 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2026
- 90 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- November 2025
- 145 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- November 2025
- 146 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 142 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- September 2025
- 176 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- September 2025
- 82 Pages
Global
From €3500EUR$4,281USD£3,144GBP

The Type 2 diabetes market, within the context of diabetes devices, encompasses a range of products designed to monitor and control blood glucose levels, as well as deliver insulin for patients in need of external sources of the hormone. Key devices include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. These devices are essential for patients to manage their condition effectively, helping to reduce the risk of complications associated with diabetes and improving overall quality of life. Advances in technology have led to the development of more accurate, user-friendly, and integrated devices, many of which can connect to smartphone apps and health management platforms to assist in tracking and analyzing diabetic data over time. This integration facilitates better personalized care and more refined treatment plans.
Companies active in the Type 2 diabetes devices market comprise a mix of established pharmaceutical companies and specialized medical device manufacturers. Some notable companies include Medtronic, Abbott Laboratories, Dexcom, Inc., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, LifeScan, Inc., and Roche Diabetes Care. These companies are at the forefront of innovation in the diabetes devices sector, investing in research and development to offer advanced solutions that address the needs of those managing Type 2 diabetes. Show Less Read more